TOPcovertip_June
6/9/08
11:00 AM
The
Page 1
Oncology
Pharmacist
The Official Newspaper of Record for the Hem/Onc Pharmacist
™
Dear Colleague: The Oncology Pharmacist features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice. A unique feature of The Oncology Pharmacist is that each issue will an include a continuing education activity accredited by the University of Nebraska Medical Center, Center for Continuing Education. Pharmacists will be able to complete the post-test and obtain credit online at no charge. Other unique features include articles specifically written for pharmacy students and residents as well as articles on practice management and financial and regulatory issues affecting the practice of pharmacy. For your free subscription, please complete and return the FREE Subscription Request card below. Postage is prepaid, so simply fill out the card and drop it in the mail. We look forward to receiving feedback on what you would like to see in future issues of The Oncology Pharmacist. —Susan Goodin, PharmD, FCCP, BCOP Editor-in-Chief
PRESORTED STANDARD
U.S. POSTAGE
PAID
For your FREE subscription to The Oncology Pharmacist™, mail the postage-paid card below or fax to 732.656.7938.
LEBANON JUNCTION, KY
PERMIT #651
TOP 6/08
❑ YES! I would like to continue to receive The Oncology Pharmacist™ as well as related ❑
educational supplements FREE! NO. Please discontinue my subscription.
Signature (Required) Date (Required) Name
Phone
■■■■■■■■■■■■■■■■■■■■■■■■■■■■■■
Address City/State/ZIP Organization’s Name E-mail ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ What is your degree/certification (more than one may apply)? ❑ PharmD ❑ BCNP
❑ PhD ❑ BCPP
❑ MSPharm ❑ BCNSP
❑ BSPharm ❑ BCNP
❑ BCOP ❑ CPhT
❑ BCPS
THE ONCOLOGY PHARMACIST™, The Official Newspaper of Record for the Hematology/Oncology Pharmacist, will provide objective, targeted coverage of the wide spectrum of oncology events, trends, products, individuals, organizations, and legislation that affect both hematology/oncology healthcare delivery and product utilization and visibility. The scope of coverage will include a unique presentation of news and events that are shaping cancer patient care written specifically by and for Hematology/Oncology Pharmacists. The Oncology Pharmacist is the ONLY newspaper in the market directed specifically to the busy Hematology/Oncology Pharmacist.
MEDICAL MINUTES HPV-related cancers of tongue and tonsils respond better to therapy
NEW TECHNOLOGY RFA ablation procedure effective alternative for treating Barrett’s esophagus
page 1
page 8
page 12
JUNE 2008 • VOL. 1, NO.2
The
CANCER CENTER PROFILE Multidisciplinary team at Cleveland Clinic Taussig Cancer Center provides patient-centered care
www.theoncologypharmacist.com
Oncology
The Official Newspaper of Record for the Hem/Onc Pharmacist
Pharmacist
™
POLICY WATCH
PHARMACY EDUCATION AND TRAINING
Organizations for the Potential Oncology Practitioner: Which Ones to Join and How Many? Patrick Medina, PharmD, BCOP Oklahoma University College of Pharmacy, Tulsa
D
uring the first year of pharmacy school, students often join numerous organizations for several reasons, including social and professional networking, resume building, and increasing knowledge in perceived areas of interest. As a
student’s interests become more focused and career paths are clarified, the number and type of organizations that he or she belongs to will also narrow. Organizations play a vital role in the professional growth of students and residents
and are also integral in maintaining lifelong learning and professional development as a pharmacist. Many organizations are available for professional and educational growth for students and residents
PHARMACY PRACTICE
Prevention and Management of
AMCP:
Oral Mucositis
President Bush signs the Genetic Nondiscrimination Information Act of 2008 into law.
page 5 Complimentary CE Credit
Continued on page 7
SUPPORTIVE CARE
W
White House photo by Evie Draper
FREE Subscription Request
New Study Looks at Use of ESAs in Real World Practice
ith the diagnosis of cancer comes the reality of an unforgiving disease process that renders the body’s natural defenses impotent. While this causes great anguish in and of itself, it is often what comes next that proves to be more troublesome. The cancer treatment itself presents formidable challenges to patients—the chemotherapy-induced neutropenia, persistent nausea and vomiting, alopecia,
SAN FRANCISCO—Prescribing practices appear to be changing when it comes to erythropoiesis-stimulating agents (ESAs), according to new data presented at the Academy of Managed Care Pharmacy’s 20th Annual Meeting and Showcase. Researchers found that between 2005 and 2006, there was a decrease in
Continued on page 13
Continued on page 6
Cetuximab-induced Hypersensitivity: Case Reports and Discussion of Management
page 16
PRESORTED STANDARD
U.S. POSTAGE
PAID
LEBANON JUNCTION, KY
PERMIT #651
RECENT FDA APPROVALS New regimens for HER2-positive breast cancer
page 10
INTERVIEW Christopher Lowe, PharmD, Taussig Cancer Center
page 12
© 2008 Green Hill HealthCare Communications, LLC
Which setting best describes where you practice? ❑ University Hospital/Ambulatory Infusion Center ❑ HMO ❑ Community Private Practice ❑ PBM ❑ Academic Teaching Institution
❑ Community Hospital ❑ Government Hospital ❑ College of Pharmacy ❑ College of Medicine ❑ Pharmaceutical Industry ❑ Other
GH Green Hill HealthCare Communications
, LLC ™
™
To which professional societies do you belong (more than one may apply)? ❑ HOPA
❑ ASCO
❑ ASH
❑ ASHP
❑ ACCP
❑ ISOPP
❑ APhA
❑ Other
Please provide all information indicated, including date and signature. • INCOMPLETE CARDS WILL NOT BE PROCESSED.
Your Innovative Partners in Medical Media